James Zidar is a Cardiology physician affiliated with Rex Hospital. OpenAlex indexes 82 publications with 4,541 citations (h-index 24).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingIndustry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
3 companies with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
78.3%Beta blocker19.1%Metoprolol Succinate67%Metoprolol Tartrate14%Carvedilol13%Atenolol4%Sotalol2%Labetalol Hcl1%Part D<11 patientsStatin14.5%Rosuvastatin Calcium44%Atorvastatin Calcium40%Pravastatin Sodium10%Simvastatin6%Part D≥115 patients+ 15 more classes in this area
Blood & clotting
18.8%Factor Xa inhibitor9.7%Eliquis84%Xarelto17%Part D≥94 patientsP2Y12 inhibitor8.1%Clopidogrel85%Prasugrel Hcl8%Brilinta7%Part D<11 patients+ 1 more class in this area
Metabolism & gastrointestinal
2.1%Proton pump inhibitor1.3%Pantoprazole Sodium83%Omeprazole17%Part D<11 patientsPotassium supplement0.6%Potassium Chloride100%Part D≥12 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Outcomes of the Novel Supreme Drug-Eluting Stent in Complex Coronary Lesions: A PIONEER III Substudy
Journal of the Society for Cardiovascular Angiography & Interventions
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Tibor Becske, MD
Rex Hospital
Ravish Sachar, MD
Rex Hospital
Jeremiah Boles, MD
Rex Hospital
Suman Wasan, MD
Rex Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”